We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Drug Delivery System Capitalizes on Monocytes' Ability to Penetrate Areas of Inflammation

By LabMedica International staff writers
Posted on 18 Jan 2015
Print article
Image: Disc-shaped microparticles use monocytes to get to their destination (Photo courtesy of the University of California, Santa Barbara).
Image: Disc-shaped microparticles use monocytes to get to their destination (Photo courtesy of the University of California, Santa Barbara).
A novel experimental drug delivery system is based on disc-shaped polymeric microparticles that are attached to monocytes, white blood cells that possess a unique ability to target and penetrate into sites of inflammation.

Investigators at the University of California, Santa Barbara (UCSB; USA) and colleagues at the Massachusetts Institute of Technology (Cambridge, MA, USA) selected the disc shape, since a nonspherical flexible shape is more durable and resistant to phagocytosis than is a rigid spherical particle.

In a paper published in the December 3, 2014, online edition of the Journal of Controlled Release, the investigators described how they capitalized on the natural ability of monocytes to target and deliver flat polymeric particles, which they called "cellular backpacks," to inflamed tissues. The cellular backpacks attached strongly to the surface of monocytes but did not undergo phagocytosis. Following attachment of backpacks, monocytes retained important cellular functions including transmigration through an endothelial monolayer and differentiation into macrophages.

In future experiments, cellular backpacks loaded with drugs will be injected into the bloodstream, whereupon they should attach to circulating monocytes and "hitchhike" to the target region. At the site of inflammation, the particles will degrade and release their drugs.

"Basically the main benefit is that you can deliver the drug in a more effective dose," said senior author Dr. Samir Mitragotri, professor of chemical engineering at the UCSB. "Take, for example, the case of chemotherapy, which often has a narrow therapeutic range: too little and the treatment is not effective, too much and it can be lethal. Because chemo travels through the bloodstream and affects all the tissues it comes in contact with, dosages are restricted at least in part based on the deleterious effect it has on other, unafflicted organs and their functions. Not only can targeted therapy ensure other body systems remain unaffected, but it could allow for higher doses of drug to the site, which could decrease treatment time. Many diseases result in inflammation. If we could target the common denominator, whether the inflammation is coming from cancer or arthritis, we could deliver the drug there."

Related Links:
University of California, Santa Barbara
Massachusetts Institute of Technology


New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.